Benjamin Thoreau։ Highlighting the Burden and Heterogeneity of ILD in ANCA-Associated Vasculitis
Benjamin Thoreau, Hospital Practitioner at CHRU Tours (Hospital), shared a post on LinkedIn about a recent article by Aglaia Chalkia et al, published in American College of Rheumatology:
”Interstitial Lung Disease in ANCA-Associated Vasculitis: A European Multicentre Study
A large retrospective European study highlights the burden and heterogeneity of ILD in AAV:
- 162 MPO-ANCA+ patients (85%)
- AAV-ILD: 76% | Isolated ANCA-ILD: 24%
- UIP most frequent pattern (57%)
- Renal involvement: 73%
Lung function trajectories differed by radiological pattern, with greater annual FVC decline in UIP/NSIP. Age and baseline FVC% independently predicted mortality, while respiratory failure correlated with fibrosis severity and initial FVC.
Important data to better phenotype and stratify prognosis in AAV-ILD.”
Title: Interstitial Lung Disease in ANCA-Associated Vasculitis: A European Multicentre Study
Authors: Aglaia Chalkia, Marusa Kotnik, Timothy J Sadler, Spyridon Katechis, Rachel Jones, Ajay Kamath, Aladdin J Mohammad, Sara Monti, Chetan Mukhtyar, Viral Nanda, Ioannis Petrakis, Dimitrios Petras, Ashnish Sinha, Pasupathy Sivasothy, Rona Smith, Kostas Stylianou, Dimitrios Vassilopoulos, Judith Babar, David Jayne
Read the Full Article on American College of Rheumatology.
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC